Passage Bio, Inc. (PASG) Misses Q3 EPS by 3c
Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.49), $0.03 worse than the analyst estimate of ($0.46).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.